Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.
Hornet Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Hornet Therapeutics's investors include 4BIO Capital.
Hornet Therapeutics is headquartered in London, United Kingdom.
Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.
Hornet Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hornet Therapeutics — Funding & Investors." VCBacked, May 23, 2024, https://www.vcbacked.co/company/hornet-therapeutics. Accessed August 15, 2026.
VCBacked. (2024). Hornet Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/hornet-therapeutics
{{cite web |title=Hornet Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hornet-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated